Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is TMAO produced by gut microbes and then oxidized by the liver?

TMAO is produced through microbial conversion of dietary precursors to trimethylamine followed by hepatic oxidation to TMAO.

PlausibleSeptember 30, 20265 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

TMAO is generated when gut microbes convert dietary precursors into trimethylamine, which the liver then oxidizes to TMAO.

laying out figure…
3 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes TMAO as a host–microbe co-metabolite formed from dietary substrates. The mechanism graph frames this as a two-step pathway in which gut microbes generate trimethylamine and the liver then oxidizes it to TMAO. Human tracer and antibiotic-reversal studies are presented as strong support for this sequence.

Verified conclusion

TMAO is a host–microbe co-metabolite: its production commonly requires both microbial processing of dietary substrates and subsequent host hepatic oxidation. The proposed sequence is strongly supported by human mechanistic studies.

Clinical and human mechanistic evidence

  • In deuterium-labeled phosphatidylcholine challenge studies, labeled TMAO appeared in plasma and urine, demonstrating conversion of a dietary choline-containing precursor into circulating and excreted TMAO.
  • Broad-spectrum antibiotics nearly abolished total and labeled TMAO production; TMAO formation returned after antibiotic withdrawal and microbiota recovery. This reversible intervention provides strong evidence that gut microbial activity is required for this dietary route.
  • Labeled L-carnitine studies independently support the same overall pathway: after steak plus labeled carnitine, TMAO rose in omnivores, was suppressed during antibiotic exposure, and reappeared with microbiota recovery.

Mechanistic explanation

  • Gut microbes convert dietary choline-containing phosphatidylcholine and L-carnitine to trimethylamine (TMA). For L-carnitine, human follow-up work identifies a two-step microbial route through γ-butyrobetaine (γBB): L-carnitine → γBB → TMA.
  • Host flavin-containing monooxygenases in the liver, including FMO3, oxidize TMA to trimethylamine N-oxide (TMAO). The tracer studies establish the net precursor-to-TMAO sequence, consistent with this established enzymatic mechanism.

Practical interpretation

  • TMAO concentration is not solely a readout of microbial TMA production: saltwater fish and seafood provide preformed TMAO, and kidney clearance is important, with concentrations rising as GFR declines.
  • Dietary pattern and individual microbiota composition can substantially affect production capacity.

Bottom line

  • The claim is well supported: gut microbial conversion of dietary precursors to TMA, followed by hepatic FMO-mediated oxidation to TMAO, is an established human metabolic pathway.

References

  1. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk | NEJM — nejm.org ↗
  2. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis — dcscience.net ↗
  3. Meat-Loving Microbes | Circulation: Cardiovascular Genetics — ahajournals.org ↗
  4. l-Carnitine in omnivorous diets induces an atherogenic gut microbial ... — pmc.ncbi.nlm.nih.gov ↗
  5. Gut Microbiota-Derived Trimethylamine N-Oxide and Kidney Function: A Systematic Review and Meta-Analysis — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes TMAO reflect gut microbial conversion of dietary precursors followed by liver oxidation?→Plausible6 sourcesDoes a normal TMAO concentration reflect the overall balance of intake, microbial production, liver oxidation, and kidney elimination?→